그래디언트

035080KOSDAQ무점포 소매업

50.3 / 100

Reference Date: 2026-04-13

Financial Score18.5 / 40

News Sentiment15.8 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but Revenue is on a declining trend. Slightly down 4.8% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Gradient operates four business segments: holding company operations, B2B e-commerce, bio-healthcare, and others. The e-commerce division contributes approximately 75% of total revenue, while the bio-healthcare segment focuses on pharmaceuticals and medical product development. The holding company segment manages and supports subsidiaries.

Number of Employees

62people

Average Salary

71.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 33.514.0Point

PBR

0.18Industry Average 0.507.0Point

Half of industry avg (excellent)

ROE

-3.28Industry Average -3.283.5Point

In line with industry avg

Debt Ratio

18.44Industry Average 18.444.0Point

In line with industry avg

Trend 2023~20250.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼5.4% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼363.0% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -2.4% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 1Neutral 1Negative 0Average Sentiment Score 70

Positive
그래디언트, 자사주 전량 소각 결정…발행주식 16% 규모
그래디언트가 보유 중인 자사주 약 225만주를 전량 소각하기로 결정하여 발행주식 총수를 감소시키고 주주환원 정책을 이행하겠다고 밝혔다.
Neutral
선급금 오해와 진실…알고보니 후급금? 일시수령 아니다
바이오 기술계약의 선급금에 대한 새로운 해석과 다양한 계약 형태에 대한 내용은 그래디언트와 직접적인 관련이 없다.

Detailed Momentum

52-week position3.0Point

52w lower range (27%)

Current 11,210Won52-week high 16,00052-week low 9,380

1-month return2.0Point

1m -4.76% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

9 totalPositive 0Neutral 9Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-08
Neutral정기주주총회결과2026-03-31
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
Neutral사업보고서 (2025.12)2026-03-23
Neutral감사보고서제출2026-03-23